Last edition
News about "next-generation biotherapeutics "
AsymBio Begins Operations at Fengxian Base to Boost Global CDMO Capacity
AsymBio has commenced commercial operations at its 130,000-square-metre Fengxian base, adding a major hub to its global CDMO network alongside its Shanghai Jinshan and Zhangjiang facilities. The new site is built to offer flexible, scalable support across all clinical phases, delivering customised CDMO solutions.
Next-generation Biotherapeutics | 08/12/2025 | By Dineshwori | 108
Harbour BioMed, AstraZeneca Advance Next-Gen Oncology Biotherapeutics Collaboration
Harbour BioMed has announced an update on the advancement of its global strategic collaboration with AstraZeneca to discover and develop next-generation biotherapeutics in oncology, including antibody-drug conjugates (ADCs) and T cell engagers.
Next-generation Biotherapeutics | 24/11/2025 | By Dineshwori | 157
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy